🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Preferential selection of viral escape mutants by CD8+ T cell ‘sieving’ of SIV reactivation from latency

PLoS Pathogens(2023)10.1371/journal.ppat.1011755Source: DataRank Database

Preferential selection of viral escape mutants by CD8+ T cell ‘sieving’ of SIV reactivation from latency is a research paper published in PLoS Pathogens (2023). On theSindex it has a DataRank of 0. It has been cited 8 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access8 citations

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (21 grants)OA: goldTopics (27)IDs (PubMed, PMC)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (15)

Kevin McCormick ORCID,M. Betina Pampena ORCID,Sadia Samer,Emily Lindemuth,Mykola Pinkevych ORCID

Live enrichment

PubMed:38032851 PMC:PMC10688670

National Institute of Allergy and Infectious Diseases

Grant: P01AI131338

National Institute of Allergy and Infectious Diseases

Grant: 1UM1AI164562-01

Enterprise for Research and Advocacy to Stop and Eradicate HIV (ERASE-HIV)

National Institute of Mental Health

Grant: R01 MH128155

National Institute of Allergy and Infectious Diseases

Grant: P30-AI-045008

National Institute of Allergy and Infectious Diseases

Grant: R01 AI162646

National Institute of Allergy and Infectious Diseases

Grant: UM1AI164570

National Health and Medical Research Council

Grant: 1173027

National Health and Medical Research Council

Grant: 1149990

Addressing the major challenges in HIV vaccine and cure research

National Cancer Institute

Grant: 75N91019D00024/HHSN261201500003I

NCI NIH HHS

Grant: HHSN261201500003I

NIH HHS

Grant: P51 OD011132

NIAID NIH HHS

Grant: UM1 AI164562

NCI NIH HHS

Grant: HHSN261201500003C

NCI NIH HHS

Grant: 75N91019D00024

NIAID NIH HHS

Grant: P30 AI045008

NIAID NIH HHS

Grant: U01 AI169767

National Institutes of Health

Grant: 1R01MH128155-01

Novel macrophage-tropic transmitted/founder SHIV model of CNS persistence to evaluate CRISPR/Cas9 gene editing

National Institutes of Health

Grant: 5R01AI162646-03

Characterizing the viral and host effector mechanisms that govern HIV-1 rebound

National Institutes of Health

Grant: 5P01AI131338-05

Immunological Strategies to Modulate SIV Rebound Following ART Interruption

National Institutes of Health

Grant: 5UM1AI164570-03

BEAT-HIV: Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy

National Institutes of Health

Grant: 5P30AI045008-10

Core--Immunology Facility

goldLicense: CC 0

publisherhttps://dx.plos.org/10.1371/journal.ppat.1011755

Europe_PMChttps://europepmc.org/articles/PMC10688670

Europe_PMChttps://europepmc.org/articles/PMC10688670?pdf=render

https://doi.org/10.1371/journal.ppat.1011755

https://pubmed.ncbi.nlm.nih.gov/38032851

Fields of Study

0303 health sciences03 medical and health sciences

MeSH Terms

CD8-Positive T-LymphocytesAnimalsMacaca mulattaHIV InfectionsSimian Acquired Immunodeficiency SyndromeEpitopesAnti-Retroviral AgentsViral LoadVirus ReplicationSimian immunodeficiency virus

Keywords

QH301-705.5Simian Acquired Immunodeficiency SyndromeHIV InfectionsRC581-607CD8-Positive T-LymphocytesViral LoadVirus ReplicationMacaca mulattaEpitopesAnti-Retroviral AgentsAnimalsSimian Immunodeficiency VirusImmunologic diseases. AllergyBiology (General)Research Article